8 completed. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 8 |
| Phase 1 | 1 | Completed 1 |
Follow Efficacy: new trials by email Literature Review of Efficacy trials Research Report on Efficacy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma Induction Immunotherapy-Toripalimab, Induction Chemotherapy-Albumin-paclitaxel combined with cisplatin, Radiotherapy - Esophageal Squamous Cell Carcinoma, Efficacy | Phase 2 | Completed | Sun Yat-sen University | 170 | 2024-02-15 | 2026-08-03 |
| A Study of GC101 TIL in Advanced Melanoma (BZ) GC101 TIL - Tumor Infiltrating Lymphocytes, Safety | Phase 1 / Phase 2 | Completed | Shanghai Juncell Therapeutics | 18 | 2023-11-08 | 2025-12-23 |
| A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes Placebo, XEN-D0501 - Efficacy, Safety | Phase 2 | Completed | Pila Pharma | 54 | 2019-02-25 | 2022-04-29 |
| Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer Bevacizumab - Metastatic Triple Negative Breast Cancer, Safety Issues | Phase 2 | Completed | Assiut University | 54 | 2018-07-01 | 2021-03-09 |
| A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma 800 μg AZD7594 once daily, 250 µg AZD7594 once daily, 58 µg AZD7594 once daily - Asthma, Efficacy | Phase 2 | Completed | AstraZeneca | 54 | 2015-06-25 | 2018-02-15 |
| Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia iloperidone, Risperidone - Schizophrenia, Iloperidone | Phase 2 | Completed | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 260 | 2012-06-01 | 2013-11-19 |
| Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer cisplatin, dexamethasone,vitamin B12, folic acid, cisplatin, gemcitabine - Non-small Cell Lung Cancer, Efficacy | Phase 2 | Completed | Sun Yat-sen University | 288 | 2009-11-01 | 2016-06-16 |
| A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer Gemcitabine and Oxaliplatin - Advanced Biliary Tract Adenocarcinoma, Gemcitabine | Phase 2 | Completed | Soonchunhyang University Hospital | 40 | 2006-09-01 | 2014-05-20 |
Asthma (1) · Carcinoma, Non-Small-Cell Lung (1) · Diabetes Mellitus, Type 2 (1) · Drug-Related Side Effects and Adverse Reactions (1) · Esophageal Squamous Cell Carcinoma (1) · Melanoma (1) · Schizophrenia (1) · Triple Negative Breast Neoplasms (1)
Neoplasms (4) · Neoplasms by Site (4) · Lung Diseases (2) · Neoplasms by Histologic Type (2) · Respiratory Tract Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Chemically-Induced Disorders (1)
Cisplatin (2) · Gemcitabine (2) · Albuterol (1) · Bevacizumab (1) · Capecitabine (1) · Dexamethasone (1) · Folic Acid (1) · Oxaliplatin (1) · Radiotherapy (1) · Risperidone (1) · Vitamin B 12 (1) · apatinib (1) · iloperidone (1) · velsecorat (1)
Sun Yat-sen University (2) · Assiut University (1) · AstraZeneca (1) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · Pila Pharma (1) · Shanghai Juncell Therapeutics (1) · Soonchunhyang University Hospital (1)
China (4) · Bulgaria (1) · Egypt (1) · Germany (1) · Lithuania (1) · South Korea (1)
Andrea Ludwig-Sengpiel, Dr. (1) · Anne-Marie Kirsten, Dr. (1) · Anneliese Linnhoff, Dr. med. (1) · Christine Grigat, Dr. (1) · Dae Sik Hong, professor (1) · Dirk Skowasch, Prof. (1) · Dorte X Gram, PhD (1) · Hui Liu, Professor (1) · Jun Guo (1) · Jutta Beier, Dr. med. (1) · Li Zhang, MD (1) · Margret Jandl, Dr. (1) · Oliver Kornmann, Dr. (1) · Rainard Fuhr, Dr. med. (1) · Tanya Kralimarkova, Dr. (1)
PMID 21383283, PMID 22415477, PMID 23075681, PMID 27501767, PMID 30777086, PMID 34407054
2014 (1), 2018 (1)